Tom B. Vaughan III

Tom Vaughan practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Tom Vaughan's NPI, 1720021736, was assigned on June 14, 2006. Tom Vaughan graduated from Heersink School of Medicine - Birmingham in 2000. Tom Vaughan's Alabama license number on file is 25883.

Tom Vaughan's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Tom Vaughan's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Tom Vaughan is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Tom Vaughan practices. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Tom Vaughan's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Tom Vaughan is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Tom Vaughan's licenses on file in 2 states: Alabama and Minnesota.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Tom Vaughan treats.

CMS data shows 328 Medicare services from Tom Vaughan across 4 procedure codes in 2024, for 152 Medicare patients. Medicare paid $14,266 for them.

CMS counts 152 Medicare patients who saw Tom Vaughan in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tom Vaughan's median patient age at 56, with 60% women.

In 2024, Tom Vaughan wrote 2,286 Medicare Part D claims for 289 patients. 50% of them were for generic drugs. CMS names the drug for 1,997 of them, across 39 drugs with 11 or more claims each, at $1,126,322 in total drug cost. In 2023, CMS named 2,062 claims across 44 drugs.

Tom Vaughan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tom Vaughan as offering telehealth.

Dmand AI links 8 papers to Tom Vaughan, published from 2018 to 2020. 2018 was the busiest year, with 2. Tom Vaughan has published most often in Surg Neurol Int. Tom Vaughan's most frequent co-authors are Kristen O. Riley, Bradford Alan Woodworth and Beverly M K Biller, MD.

Dmand AI links Tom Vaughan to 4 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Dwarfism, Pituitary, Hypopituitarism and Acromegaly.

CMS Open Payments shows 5 general payments to Tom Vaughan from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Medtronic MiniMed, Inc. paid the most, $104.

Dmand AI lists 1 award for Tom Vaughan, most recently CMS Stage 1 2012 in 2012.

Tom Vaughan graduated from Heersink School of Medicine - Birmingham in 2000.

Tom Vaughan is in network with 11 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.